Skip to main content
Caplight Logo









RinuaGene Biotechnology

RinuaGene Biotechnology

Private
SuzhouHealthcare & Life Scienceshttps://rinuagene.com/

Company Overview

RinuaGene Biotechnology is a biotechnology company that develops innovative mRNA-based therapeutics and vaccines for oncology and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

mRNA therapeuticslipid nanoparticleLNPmRNA vaccinedrug discovery platformbiotech CDMOGMP productioncircular mRNAAI drug discoveryprotein replacement therapyRNA engineeringoncology therapeuticschemistry manufacturing and controlsCMCnext-gen mRNA

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RinuaGene Biotechnology Comparables

Compare RinuaGene Biotechnology with similar companies based on industry and business-model similarity.

RinuaGene Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RiboX Therapeutics
85%
Therorna Inc.
84%
Immorna Biotherapeutics
84%

RinuaGene Biotechnology Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

RinuaGene Biotechnology Filings

Explore SEC and related filing metadata, where available.

RinuaGene Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RinuaGene Biotechnology's valuation, stock price, and market status.

Is RinuaGene Biotechnology a public or private company?

RinuaGene Biotechnology is a private company.

What is the current stock price of RinuaGene Biotechnology?

RinuaGene Biotechnology is a private company with no public stock price. Caplight tracks RinuaGene Biotechnology's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is RinuaGene Biotechnology worth (valuation)?

Valuation information for RinuaGene Biotechnology is not publicly available.

Can I buy RinuaGene Biotechnology stock?

RinuaGene Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RinuaGene Biotechnology's last funding round?

Funding round information for RinuaGene Biotechnology is not publicly available.

Who are the main investors in RinuaGene Biotechnology?

Investor information for RinuaGene Biotechnology is not publicly disclosed.

Will RinuaGene Biotechnology IPO soon?

No public IPO plans have been announced for RinuaGene Biotechnology.

How can I track RinuaGene Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RinuaGene Biotechnology's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSuzhou
Employee Range1
Year Founded2021
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?